Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionCentaurus Financial, Inc.
Latest Disclosed Ownership19,494 shares
Latest Disclosed Value $ 1,182
Centaurus Financial, Inc. reports 95.37% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 18, 2026 - Centaurus Financial, Inc. filed a 13F-HR form disclosing ownership of 19,494 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,021,875 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 9,978 shares of Bristol-Myers Squibb Company. The current value of the position is $924,698 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 19,494 9,516 95.37 1 0.0562
2026-02-13 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 9,978 -605 -5.72 1 0.0246
2025-11-20 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 10,583 -1,588 -13.05 0 0.0224
2025-08-29 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,171 49 0.40 1 0.0329
2025-05-15 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,122 -53 -0.44 1 0.0447
2025-03-12 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,175 1,256 11.50 1 0.0421
2024-11-12 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 10,919 1,920 21.34 1 0.0359
2024-09-23 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 8,999 -1,837 -16.95 0 0.0249
2024-05-14 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 10,836 -1,188 -9.88 1 0.0411
2024-02-26 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,024 -605 -4.79 1 0.0469
2023-11-13 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,629 24 0.19 1 0.0637
2023-08-15 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,605 -5,857 -31.72 1 -100.00 0.0706
2023-05-18 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 18,462 816 4.62 1 0.00 0.1025
2023-02-13 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,646 98 0.56 1 -99.92 0.1194
2022-12-05 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,548 -52 -0.30 1,247 -7.97 0.1216
2022-08-02 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,600 -2,787 -13.67 1,355 -9.00 0.1336
2022-05-13 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 20,387 -2,791 -12.04 1,489 3.04 0.1175
2022-02-01 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 23,178 1,052 4.75 1,445 10.39 0.1093
2021-11-12 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 22,126 990 4.68 1,309 -7.29 0.1097
2021-08-10 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,136 2,078 10.90 1,412 17.37 0.1189
2021-04-30 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 19,058 -8,063 -29.73 1,203 -28.48 0.1186
2021-01-25 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 27,121 811 3.08 1,682 6.05 0.1770
2020-11-12 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 26,310 -20,292 -43.54 1,586 -42.12 0.2195
2020-08-13 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 46,602 13,970 42.81 2,740 50.63 0.4050
2020-04-21 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 32,632 -596 -1.79 1,819 -14.72 0.3635
2020-02-12 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 33,228 11,437 52.48 2,133 93.03 0.2987
2019-11-09 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 21,791 628 2.97 1,105 15.10 0.1730
2019-08-15 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 21,163 20,386 2,623.68 960 5,900.00 0.1512
2019-07-01 2019-03-31 13F/A-1 BRISTOL MYERS SQUIBB COM 110122108 777 177 29.50 16 33.33 0.0958
2019-05-13 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 16,289 15,689 777
2019-02-12 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 600 -9,400 -94.00 12 -97.98 0.0861
2018-11-02 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 10,000 -8,323 -45.42 595 -41.32 0.1075
2018-08-14 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 18,323 13,228 259.63 1,014 214.91 0.1400
2018-05-07 2018-03-31 13F BRISTOLMYERSSQUIBBCO COM 110122108 5,095 221 4.53 322 7.69 0.0755
2018-02-09 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 4,874 4,874 299 0.0775
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.